Rivaroxaban
ТаблеткиOral anticoagulant from the group of direct factor Xa inhibitors
Important
Indications
Rivaroxaban is indicated for use in adults for the prevention of:
- death due to cardiovascular causes, myocardial infarction and stent thrombosis in patients after acute coronary syndrome (ACS) with elevated, cardiac-specific biomarkers, in combination therapy with acetylsalicylic acid (ASC) or with ASC and clopidogrel or ticlopidine;
- stroke, myocardial infarction and death due to cardiovascular causes, as well as prevention of acute limb ischaemia and total mortality in patients with coronary heart disease (CHD) or peripheral arterial disease (PAD) in combination therapy with ASC.
Contraindications
Do not use Rivaroxaban:
- If you are allergic to rivaroxaban or any other components of the drug (listed in section 6 of the leaflet);
- if you have clinically significant active bleeding (e.g. intracranial haemorrhage, gastrointestinal bleeding);
- if you have diseases or conditions associated with an increased risk of major bleeding (e.g. existing or recent gastrointestinal ulcer, malignancy with a high risk of bleeding, recent trauma to the brain or spinal cord, recent brain, spinal cord or eye surgery, recent intracranial haemorrhage, diagnosed or suspected oesophageal varices, arteriovenous malformations (occurrence of m bleeding), or if you are at high risk of bleeding.
- If you are taking any other anticoagulants as concomitant therapy (e.g. heparin, low molecular weight heparins: enoxaparin, dalteparin, fraxiparin, other heparin derivatives - fondaparinux, oral anticoagulants: warfarin, apixaban, dabigatran), unless you are being switched from or to therapy with Rivaroxaban, or if heparin is prescribed in low doses to maintain patency of a central venous or arterial catheter;
- if you have had a stroke or transient ischaemic attack and are being treated for ACS with antiaggregants;
- if you have ischaemic heart disease or peripheral arterial disease with previous brain haemorrhage (stroke) or blockage of small arteries delivering blood to brain tissue (lacunar stroke) or thrombus formation in brain vessels (ischaemic, non-lacunar stroke) within the last month and you are taking ASCs at the same time;
- if you have liver disease with a high risk of bleeding (impaired blood clotting ability);
- if you have severe renal impairment (creatinine clearance < 15 ml/min);
- if you are pregnant or breastfeeding.
Usage
Always use the medicine in full compliance with the leaflet or with the recommendations of your doctor or pharmacist. If in doubt, consult your doctor.
Recommended dose
The recommended dose is 2.5 mg (1 tablet) 2 times a day. Rivaroxaban is not prescribed alone, without other antithrombotic medicines. Your doctor will also prescribe ASC (usually 75 100 mg per day) or combination of ASC with clopidogrel or ticlopidine (after ACS) (75-100 mg per day of ASC and 75 mg per day of clopidogrel or standard daily dose of ticlopidine).
Have questions? Contact Us
Drugs in the category Cardiology
Has contraindications. Needs specialist overview.